Company information:
T-Therapeutics Limited (No: 14097070)
Address: ABINGTON HALL, GRANTA PARK, CAMBRIDGE, CB21 6AL, UNITED KINGDOM
Status: Active
Incorporated: 05-Oct-2022
Accounts Next Due: 30-Sep-2024
Next Confirmation Statement Due: 06-Jan-2024
Industry Class: 72110 - Research and experimental development on biotechnology
Current Director: SAMUEL BJORK ( DOB: Aug-1988 From: Nov-2022 )
Current Director: ALLAN BRADLEY ( DOB: Feb-1960 From: May-2022 )
Current Director: ALLAN BRADLEY ( DOB: Feb-1960 From: May-2022 )
Current Director: DAVID HUNG ( DOB: Jun-1957 From: Jan-2024 )
Current Director: GRAZIANO SEGHEZZI ( DOB: Feb-1969 From: Nov-2022 )
Current Director: NIHAL SINHA ( DOB: Aug-1994 From: Nov-2022 )
Current Director: ROBERT GILES TANSLEY ( DOB: Dec-1963 From: Nov-2022 )
Persons of Significant Control:
Dr Allan Bradley, Abington Hall Granta Park, Cambridge, CB21 6AL, United Kingdom: Ownership of shares – More than 25% but not more than 50%, Ownership of voting rights - More than 25% but not more than 50% (Notified: 2022-05-10)